Paul A. Friedman

Insider Reports History

Entity
Individual
Location
C/O Incyte Corporation, 1801 Augustine Cut Off, Wilmington, DE
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul A. Friedman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 656K $184M $280.00 Jun 25, 2024 By SQN LLC
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 186K $52.2M $280.00 Jun 25, 2024 Direct
Prelude Therapeutics Inc Director Director Stock Option (Right to Buy) 23.5K Jun 14, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 1.11K Jun 25, 2024 Direct
ALEXION PHARMACEUTICALS, INC. Director Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct

Insider Reports Filed by Paul A. Friedman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 25, 2024 2 $0 4 Jun 27, 2024 Director
PRLD Prelude Therapeutics Inc Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Apr 8, 2024 9 -$6.22M 4 Apr 10, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Apr 3, 2024 26 -$17.3M 4 Apr 5, 2024 Director
PRLD Prelude Therapeutics Inc Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 -$550K 4 Jan 18, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 $0 4 Jan 18, 2023 Chief Executive Officer, Director
PRLD Prelude Therapeutics Inc Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Executive Officer, Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 1 $0 4 Jul 23, 2021 Director
PRLD Prelude Therapeutics Inc Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
ALXN ALEXION PHARMACEUTICALS, INC. May 20, 2021 2 $0 4 May 24, 2021 Director